HHIP inhibits Shh signaling by sequestering Hh ligands which then cannot activate the pathway, and its epigenetically mediated downregulation was observed in gastrointestinal, hepatocellular, and pancreatic tumors [43–46]. The gene discussed is HHIP; the disease is pancreatic neoplasm.